Literature DB >> 4564239

Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease.

R Groszmann, B Kotelanski, J N Cohn, I M Khatri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4564239     DOI: 10.1016/0002-9343(72)90188-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  31 in total

Review 1.  The endocrinology and pathophysiology of alcoholic cirrhosis and functional renal failure--a review.

Authors:  E S Domurat; A N Elias
Journal:  J Natl Med Assoc       Date:  1992-02       Impact factor: 1.798

Review 2.  Clinical pharmacokinetics in patients with liver disease.

Authors:  A J McLean; D J Morgan
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

3.  Assessment of portosystemic shunting from superior mesenteric vein by duodenal administration of iodoamphetamine I123.

Authors:  T Kashiwagi; H Fukui; T Kozuka; M Goto; Y Takei; A Kasahara; S Kawano; H Fusamoto; T Kamada; M Azuma
Journal:  Eur J Nucl Med       Date:  1992

4.  Evaluation of portal-systemic shunting in rats from mesenteric and splenic beds.

Authors:  R E Stauber; F W Ruthardt; W N Tauxe; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

5.  Histological changes in the liver and indices of drug metabolism in alcoholics.

Authors:  E A Sotaniemi; J Ahlqvist; R O Pelkonen; H Pirttiaho; P V Luoma
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

6.  Treatment of ascites in patients with cirrhosis of the liver.

Authors:  V Arroyo; P Ginés; J Rodés
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

7.  Hemodynamic patterns in human hepatic cirrhosis: a prospective randomized study of the hemodynamic sequelae of distal splenorenal (Warren) and mesocaval shunts.

Authors:  F A Reichle; O E Owen
Journal:  Ann Surg       Date:  1979-10       Impact factor: 12.969

8.  Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.

Authors:  H I Pirttiaho; E A Sotaniemi; R O Pelkonen; U Pitkänen; M Anttila; H Sundqvist
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

Review 9.  Propranolol disposition in chronic liver disease: a physiological approach.

Authors:  R A Branch; D G Shand
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

10.  Evaluation of portal circulation through the superior mesenteric vein with an enteric capsule of [123I]iodoamphetamine.

Authors:  S Shiomi; T Kuroki; Y Miyazawa; T Ueda; T Takeda; S Nishiguchi; S Nakajima; K Kobayashi; H Ochi
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.